PI Publications
- 2025Effect of the radioprotector chlorophyllin on graft versus leukemia response in experimental allogeneic hematopoietic stem cell transplantation. Journal of Ayurveda and Integrative Medicine. 16(2):101109. PMID: 39919359.
Gupta SK, Yadav S, Sharma D, Sandur SK, Khattry N, Goda JS, Gota V
- 2024Dosimetric impact of voluntary Deep Inspiration Breath Hold (DIBH) in mediastinal hodgkin lymphomas: A comparative evaluation of three different Intensity Modulated Radiation Therapy (IMRT) delivery methods using voluntary DIBH and free breathing techniques. Cancers. 16(4): 690. PMID: 38398081
Mohanty S, Patil D, Joshi K, Gamre P, Mishra A, Khairnar S, Kakoti S, Nayak L,Punatar S, Jain J, Phurailaptam R, Goda J
Clinical outcomes following surgery and radiation therapy in a real world setting. World Neurosurgery. 181: e809-e819. PMID: 37923012Ghosh S, Goda J, Chatterjee A, Shetty P,Sahay A, Dasgupta A, Epari S, Sahu A, Singh V, Gupta T, Moiyadi A, Jalali R
A Retrospective cohort study to evaluate the outcomes of HIV-associated high-grade B-Cell Non-Hodgkin Lymphoma (NHL) treated with dose adjusted EPOCH (+/−R) regimen. Indian Journal of Haematology and Blood Transfusion. 40(1):36-42.PMID: 38312196Thorat J, Sengar M, Chanana R, Kapoor A, Singh A, Bonda A, Menon H, Bagal B, Laskar S, Khanna N, Goda JS, Epari S, Gujral S, Agarwal A, Sawant S, Daddi A, Shet T, Ghandade N, Jain H
Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy. Nanoscale. 16(13):6330-6364. PMID: 38470224Sandhbhor P, Palkar P, Bhat P, Bhat S, John G, Goda J
How does deep learning/ machine learning perform in comparison to radiologists in distinguishing Glioblastomas (or grade IV Astrocytomas) from Primary CNS Lymphomas?: A meta-analysis and systematic review. Clinical Radiology.79(6):460-472. PMID: 38614870Guha A, Halder S, Shinde S, Gawade J, Munnolli S, Talole S, Goda J
Long-term clinical outcomes of combined modality therapy for advanced-stage Hodgkin lymphoma in the PET era: A retrospective study. Indian Journal of Medical Research. 159(2):193-205. PMID: 38577858Chugh S, Panda G, Mokal S, Jain H, Bagal B, Khanna N, Epari S, Punatar S, Nayak L, Gokarn A, Khattry N, Sengar M, Laskar S, Goda JS
Drug development in LMICs: could the emerging Indian model usher the southeast Asian region? The Lancet Regional Health - Southeast Asia. 29: 100464. PMID: 39247446Pant B, Goda J, Gota V
Patterns of Care for Brain Metastases in Asia: A Real-World Survey Conducted by the Federation of Asian Organizations for Radiation Oncology. JCO Global Oncology. 10:e2400222. PMID: 39418623Uchinami Y, Dasgupta A, Nishioka K, Handoko, Goda JS, Kim JW, Zaid RM, Kai Yun O, Mehmood H, Chitapanarux I, Chopra S, Aoyama H
Dosimetric impact of voluntary Deep Inspiration Breath Hold (DIBH) in mediastinal hodgkin lymphomas: A comparative evaluation of three different Intensity Modulated Radiation Therapy (IMRT) delivery methods using voluntary DIBH and free breathing techniques. Cancers. 16(4): 690. PMID: 38398081Mohanty S, Patil D, Joshi K, Gamre P, Mishra A, Khairnar S, Kakoti S, Nayak L,Punatar S, Jain J, Phurailaptam R, Goda J
Clinical outcomes following surgery and radiation therapy in a real world setting. World Neurosurgery. 181:e809-e819. PMID: 37923012Ghosh S, Goda J, Chatterjee A, Shetty P,Sahay A, Dasgupta A, Epari S, Sahu A, Singh V, Gupta T, Moiyadi A, Jalali R
A Retrospective cohort study to evaluate the outcomes of HIV-associated high-grade B-Cell Non-Hodgkin Lymphoma (NHL) treated with dose adjusted EPOCH (+/−R) regimen. Indian Journal of Haematology and Blood Transfusion. 40(1):36-42.PMID: 38312196Thorat J, Sengar M, Chanana R, Kapoor A, Singh A, Bonda A, Menon H, Bagal B, Laskar S, Khanna N, Goda JS, Epari S, Gujral S, Agarwal A, Sawant S, Daddi A, Shet T, Ghandade N, Jain H
Paper-based point of care diagnostics for cancer biomarkers. Sensors and Diagnostics. 3: 504-53Bhardwaj P, Arora B, Saxena S, Singh S, Palkar P, Goda J, Banerjee R
Long‑term Survivor of Intravascular Central Nervous System (CNS) Lymphoma: An Unusual Phenomenon. Indian Journal of Hematology and Blood Transfusion.Guha A, Jose S, Sakhdeo U, Seth T, Punatar S, Goda J
- 2023Institutional patterns of care of diffuse intrinsic pontine glioma. Neurology India. 71(1):72-78. PMID: 36861577
Krishnatry R, Mani S, Manjali JJ, Rane PP, Chatterjee A, Goda JS, Janu A, Sahu A, Gupta T, Jalali R
Multiparametric magnetic resonance imaging correlates of isocitrate dehydrogenase mutation in WHO high-Grade astrocytomas. Journal of Personalized Medicine. 13(1): 72. PMID: 36675733Sahu A, Patnam N, Goda JS, Epari S, Sahay A, Mathew R, Choudhari A, Desai S, Dasgupta A, Chatterjee A, Pratishad P,Shetty P, Moiyadi A, Gupta T
Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model. Drug Delivery and Translational Research. 13(2):608-626. PMID: 36245060.Sandbhor P, Goda J, Mohanty B, Gera P, Yadav S, Chekuri G, Chaudhari P, Dutt S, Banerjee R
Lenalidomide following whole-brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy. Br J Haematol. 201(1):150-153. PMID: 3668236Bagal B, Sarma R, Dey S, Nayak L, Bonda A, Goda J, Khanna N, Dasgupta A, Kakoti S, Chatarjee A, Jain H, Epari S, Laskar S, Sengar M, Gupta T
Demographic, pattern of care and outcomes of primary CNS lymphoma-experience from a tertiary care cancer center in India. Indian Journal of Hematology and Blood Transfusion. 39(1):57-70. PMID: 36699441Das S, Bagal B, Jain H, Kashyap L, Anbarsan S, Sharma A, Bondili S, Nayak L, Thorat J, Mirgh S, Gokarn A, Punatar S, Sahay A, Epari S, Tembhare P, Shetty P, Khanna N, Goda J, Moiyadi A, Gupta T, Sengar M, Khattry N, Menon H
Metabolic tumor parameters complement clinicopathological factors in prognosticating advanced stage Hodgkin Lymphoma. Asia Oceania Journal of Nuclear Medicine & Biology. 11(2):111-121 PMID: 37324230Mohite A, Rangarajan V, Goda J, Chugh S, Agrawal A, Sengar M
Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option. Frontiers in Immunology. 14:1118246. PMID: 37006286Asija S, Chatterjee A, Goda JS, Yadav S, Chekuri G, Purwar R
Primary intracranial germ cell tumors: A study with an integrated clinicopathological approach. Neurology India. 71(3): 500-508. PMID: 37322747Sahay A, Epari S, Chinnaswamy G, Chatterjee A, Goda JS, Patil V, Moyiadi A, Shetty P, Singh V, Sahu A, Choudhary A, Janu A, Gupta T
Computerized tomography-based first order tumor texture features in non-small cell lung carcinoma treated with concurrent chemoradiation: A simplistic and potential surrogate imaging marker for survival. Journal of Cancer Research and Therapeutics. 19(2): 366-375.PMID: 37313912Nayak P, Sinha S, Goda JS, Sahu A, Joshi K, Choudhry O Roy, Mhatre R, Mummudi N, Agarwal JP
Machine-Learning-Based Radiomics for Classifying Glioma Grade from Magnetic Resonance Images of the Brain. Journal of Personalized Medicine.13(6):920. PMID: 37373909Kumar A, Jha AK, Agarwal JP, Yadav M, Badhe S, Sahay A, Epari S, Sahu A, Bhattacharya K, Chatterjee A, Ganeshan B, Rangarajan V, Moyiadi A, Gupta T, Goda JS
Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects. Frontiers in Oncology. 13:1168454. PMID: 37483515Hegde MM, Sandbhor P, Aishwarya J, Gota V, Goda JS
Primary central nervous system lymphoma: Comprehension of cell-of-origin subtypes. Indian Journal of Pathology Microbiology. 66(3):549-555. PMID: 37530337Rao S, Epari S, Shet TM, Gujral S, Jain H, Bagal B, Senagar M, Shetty P, Moiyadi A, Goda JS, Gupta T
- 2022Clinical Audit of Survival Outcomes and Prognostic Factors in Adolescents and Adults with Medulloblastoma. Journal of Adolescent and Young Adult Oncology.11(1):68-77. PMID: 33891492
Patil R, Gupta T, Maitre M, Dasgupta A, Sahay A, Epari S, Shirsat N, Chatterjee A, Krishnatry R, Goda JS, Moiyadi A, Patil V, Chinnaswamy G, Bano N, Jalali R
Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma. Strahlentherapie und Onkologie. 198(3):291-303. PMID: 35059761Dasgupta A, Gupta T, Maitre M, Kalra B, Chatterjee A, Krishnatry R, Goda JS, Shirsat N, Epari S, Sahay A, Janu A, Pungavkar S, Chinnaswamy G, Patil V, Moiyadi A, Shetty P, Jalali R
Loco-regional radiosensitizing nanoparticles-in-gel augments head and neck cancer chemoradiotherapy. Journal of Controlled Release. 343:288-302. PMID: 35101477.Bhardwaj P, Gota V, Vishwakarma K, Pai V, Chaudhari P, Mohanty B, Thorat R, Yadav S, Gurjar M, Goda JS, Banerjee R
Impact of immobilisation and image guidance protocol on planning target volume margins for supine craniospinal irradiation. Reports of Practical Oncology and Radiotherapy.27(2):250-259 PMID: 36299390Krishnatry R, Gudi S, Siwach A, Patil A, Rajesh KR, Shekhar H, Sutar V, Chatterjee A, Goda J, Jalali R, Gupta T
Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial. BMJ Open. 12(4): e055765. PMID: 35387819Chopra S, Goda J, Mittal P, Mulani J, Pant S, Pai V, Kannan S, Deodhar K, Krishnamurthy M, Menon S, Charnalia M, Shah S, Rangarajan V, Gota V, Naidu L, Sawant S, Thakkar P, Popat P, Ghosh J, Rath S, Gulia S, Engineer R, Mahantshetty U, Gupta S
Imaging for plasma cell dyscrasias: What, when, and how? Frontiers in Oncology. 12: 825394. PMID: 35402253Guha A, Vijan A, Agarwal U, Goda JS, Mahajan A, Shetty N, Khattry N
Machine-learning approach to predict molecular subgroups of medulloblastoma using multiparametric MRI-based tumor radiomics. British Journal of Radiology. 23:20211359. PMID: 35262407.Saju AC, Chatterjee A, Sahu A, Gupta T, Krishnatry R, Mokal S, Sahay A, Epari S, Prasad M, Chinnaswamy G, Agarwal JP, Goda JS
Diffuse large B-Cell lymphoma in the elderly: Real-world outcomes from a developing country. Clinical Lymphoma Myeloma and Leukemia. 22(10): e898-e906. PMID: 35810145Jobanputra K, Nayak L, Jain H, Shet T, Epari S, Bonda VN, Thorat J, Bagal B, Laskar S, Rangarajan V, Agrawal A, Gujral S, Khanna N, Goda J, Sengar M
High-dose salvage re-irradiation in recurrent/progressive adult diffuse gliomas: development of a novel prognostic scoring system. Cancer Radiotherapy. 26(8):994-1001.PMID: 35715356Maitre M, Gupta T, Maitre P, Chatterjee A, Dasgupta A, Moiyadi A, Shetty P, Epari S, Sahay A, Patil V, Krishnatry R, Goda J, Jalali R
Long-term clinical outcomes and sequelae of therapy in early-stage orbital mucosa-associated lymphoid tissue lymphoma. Clinical Lymphoma Myeloma and Leukemia. 22(7):513-522. PMID: 35027338Panda G, Kalra B, Rishi A, Khanna N, Kakoti S, Sridhar E, Shet T, Sengar M, Nayak L, Bagal B, Jain H, Laskar S, Goda J
Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds. International Reviews of Immunology.41(6):582-605. PMID: 35938932Asija S, Chatterjee A, Yadav S, Chekuri G, Karulkar A, Jaiswal AK, Goda JS, Purwar R
Bio-polymeric transferrin-targeted temozolomide nanoparticles in gel for synergistic post-surgical GBM therapy. Nanoscale. 14(35):12773-12788. PMID: 36001382.Sandbhor P, Goda JS, Mohanty B, Chaudhari P, Dutt S, Banerjee R
Clinical utility of CAR T cell therapy in brain tumors: Lessons learned from the past, current evidence and the future stakes. International Reviews of Immunology.41(6):606-624.PMID: 36191126Chatterjee A, Asija S, Yadav S, Purwar R, Goda JS
Using artificial intelligence for optimization of the processes and resource utilization in radiotherapy. JCO Global Oncology. PMID: 36395438.Krishnamurthy R, Mummudi N, Goda JS, Chopra S, Heijmen B, Swamidas J
Compliance of radiotherapy treatment at a tertiary cancer center in India—A clinical audit. Indian Journal of Medical and Paediatric Oncology. 43(1): 84-91.Khanna N, Kumar A, Sehra N, Ghosh -Laskar S, Mummudi N, Gupta T, Tibdewal A, Pathak R, Wadasadawala T, Krishnatry R, Chopra S, Goda J, Chatterjee A, Budrukkar A, Gurram L, Engineer R, Murthy V, Swain M, Laskar S, Sarin R, Agarwal J
- 2021Safety and efficacy of concurrent carboplatin during full-dose craniospinal irradiation for high-risk/metastatic medulloblastoma in a resource-limited setting. Pediatric Blood & Cancer: e28925. PMID: 33533557
Gupta T, Sinha, S, Chinnaswamy G, Vora T, Prasad M, Bhat V, Goda JS, Krishnatry R, Chatterjee A, Epari S, Sahay A, Moiyadi A, Shetty P, Patil V, Khatua S, Jalali R, Kurkure P
High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting? Clinical and Translational Oncology. 23(7):1358-1367. PMID: 33528810.Gupta T, Maitre M, Maitre P, Goda JS, Krishnatry R, Chatterjee A, Moiyadi A, Shetty P, Epari S, Sahay A, Patil V, Jalali R
Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma. Japanese Journal of Clinical Oncology. 51(5): 762-768. PMID: 33521824Krishnatry R, Manjali JJ, Chinnaswamy G, Chatterjee A, Goda JS, Janu A, Sahu A, Jalali R, Gupta T
Prospective longitudinal assessment of quality of life. and activities of daily living as patient-reported outcome measures in recurrent/progressive glioma treated with high-dose salvage re-irradiation. Clinical Oncology (R Coll Radiol). 33(3):e155-e165. PMID: 32917486Maitre P, Gupta T, Maitre M, Goda J, Krishnatry R, Chatterjee A, Sridhar E, Sahay A, Mokal S, Moiyadi A, Shetty P, Patil V, Jalali R
Clinico-radiological characteristics, histo-pathological features and long-term survival outcomes in central neurocytoma: A single-institutional audit. Journal of Clinical Neurosciecne. 84:91-96. PMID: 33358093Pawar D, Chatterjee A, Epari S, Sahay A, Janu A, Krishantry R, Goda JS, Shetty P, Moiydai A, Gupta T
Upfront therapy of aggressive/high-risk low-grade glioma: single institution outcome analysis of temozolomide-based radio-chemotherapy and adjuvant chemotherapy. World Neurosurgery.154: e176-e184 PMID: 34245877.Anand S, Chatterjee A, Gupta T, Panda P, Moiyadi A, Epari S, Patil V, Krishnatry R, Goda JS, Jalali R
3,3′-diselenodipropionic acid (DSePA) induces reductive stress in A549 cells triggering p53-independent apoptosis: A novel mechanism for diselenides. Free Radical Biology and Medicine. 175: 1-17. PMID: 34425189Gandhi V, Gandhi K, Kumbhare L, Goda J, Gota V, Priyadarsini K, Kunwar A
Ultrasound augments on-demand breast tumor radiosensitization and apoptosis through a tri-responsive combinatorial delivery theranostic platform. Nanoscale. 13(40):17077-17092.PMID: 34622906Bhardwaj P, Goda JS, Pai V, Chaudhari P, Mohanty B, Pai T, Vishwakarma K, Thorat R, Wadasadawala T, Banerjee R
Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models. Nanoscale. 14(1): 108-126. PMID: 34897360Sandbhor P, Goda J, Mohanty B, Chaudhari P, Dutt S, Banerjee R
TERT promoter mutation in adult glioblastomas: It's correlation with other relevant molecular markers. Neurology India. 69:126-34. PMID: 33642283Barange M, Epari S, Gurav M, Shetty O, Sahay A, Shetty P, Goda J, Moiyadi A, Gupta T, Jalali R
DUSP6 regulates radio-sensitivity in glioblastoma by modulating the recruitment of p-DNAPKcs at DNA double-strand breaks. Journal of Cell Science 134 (24): jcs259520. PMID: 34792128.Nair J, Syed SB, Mahaddalkar T, Ketkar M, Thorat R, Sastri Goda J, Dutt S
- 2020Tumor radiomic features complement clinico-radiological factors in predicting long-term local control and laryngectomy free survival in locally advanced laryngo-pharyngeal cancers. British Journal of Radiology. 93(1109): 20190857. PMID: 32101463
Agarwal JP, Sinha S, Goda JS, Joshi K, Mhatre R, Kannan S, Laskar SG, Gupta T, Murthy V, Budrukkar A, Mummudi N, Ganeshan B
A randomized trial of Stereotactic vs. Conventional radiotherapy in young patients with low grade brain tumors: Occupational therapy based neurocognitive data. Neuro-Oncology Advances. 2(1): vdaa130.Chatterjee A, Goda JS, Gupta T, Kamble R, Mokal S, Krishnatry R, Sarin R, Jalali R
Primary diffuse large B cell lymphoma of Uterine Cervix: Treatment outcomes of a rare entity with literature review. Cancer Reports. 3(5):e1264. PMID: 32761885Goda JS, Gaikwad U, Narayan A, Kurkure D, Yadav S, Khanna N, Jain H, Bagal B, Epari S, Singh P, Sengar M, Laskar S
Hippocampal radiotherapy dose-constraints for predicting long-term neurocognitive outcomes: Mature data from a prospective trial in young patients with brain tumors. Neuro-Oncology. 22(11):1677. PMID: 32227185Goda JS, Dutta D, Krishna U, Goswami S, Gupta T, Kothavade V, Kannan S, Maitre M, Bano N, Jalali R
Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma. Journal of Neuro-Oncology. 147(2):405-4 PMID: 32072441Gupta T, Maitre M, Gupta P, Krishanty R, Chatterjee A, Moiyadi AV, Shetty P, Singh V, Chinnaswamy G, Epari S, Sahay A, Patil V, Goda JS
Coronavirus disease 2019 pandemic and its implications on triaging patients with brain tumors for surgery, radiotherapy, and chemotherapy. Cancer Research, Statisitcs and Treatment. 3(Suppl S1): 49-53.Jalali R, Goda JS, Patil V
Melanotic schwannoma, a deceptive misnomer for a tumor with relative aggressive behavior: A series of 7 cranial and spinal Cases. International Journal of Surgical Pathology. 28(8):850-858 PMID: 32456496Sahay A, Epari S, Gupta P, Goda J, Shetty P, Patil V, Bajpai J, Moiyadi A, Gupta T